Tenon Medical (TNON) Competitors

Tenon Medical (NASDAQ:TNON) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Which has more volatility and risk, TNON or CLGN?

Tenon Medical has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in TNON or CLGN?

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 4.7% of Tenon Medical shares are owned by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts rate TNON or CLGN?

Tenon Medical presently has a consensus target price of $4.67, suggesting a potential upside of 295.48%. CollPlant Biotechnologies has a consensus target price of $12.50, suggesting a potential upside of 473.39%. Given CollPlant Biotechnologies' stronger consensus rating and higher probable upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
CollPlant Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Is TNON or CLGN more profitable?

Tenon Medical has a net margin of -413.88% compared to CollPlant Biotechnologies' net margin of -2,680.00%. CollPlant Biotechnologies' return on equity of -77.05% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-413.88%	-1,785.88%	-164.26%
CollPlant Biotechnologies	-2,680.00%	-77.05%	-61.43%

Does the media refer more to TNON or CLGN?

In the previous week, Tenon Medical and Tenon Medical both had 2 articles in the media. Tenon Medical's average media sentiment score of 1.16 beat CollPlant Biotechnologies' score of 0.43 indicating that Tenon Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Tenon Medical	Positive
CollPlant Biotechnologies	Neutral

Which has stronger valuation and earnings, TNON or CLGN?

CollPlant Biotechnologies has lower revenue, but higher earnings than Tenon Medical. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.28M	2.23	-$15.58M	-$27.23	-0.04
CollPlant Biotechnologies	$515K	48.49	-$7.02M	-$1.46	-1.49

Does the MarketBeat Community prefer TNON or CLGN?

CollPlant Biotechnologies received 135 more outperform votes than Tenon Medical when rated by MarketBeat users. However, 100.00% of users gave Tenon Medical an outperform vote while only 60.00% of users gave CollPlant Biotechnologies an outperform vote.

Company	Underperform	Outperform
Tenon Medical	Outperform Votes 6 100.00%	Underperform Votes No Votes
CollPlant Biotechnologies	Outperform Votes 141 60.00%	Underperform Votes 94 40.00%

Summary

CollPlant Biotechnologies beats Tenon Medical on 11 of the 18 factors compared between the two stocks.